Evidence map›Paper›PMID 21911470›Full record

ArticleInfection and immunity2011

Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells.

Joyce A Ibana, Robert J Belland, Arnold H Zea, Danny J Schust, Takeshi Nagamatsu, Yasser M AbdelRahman, David J Tate, Wandy L Beatty, Ashok A Aiyar, Alison J Quayle

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  6. Article
  7. The role of tryptophan inFrontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. IL-10Frontiers in immunology · 2021
    Article
  13. Frontiers in immunology · 2021
    Article
  14. Indoleamine 2,3-Dioxygenase Cannot InhibitFrontiers in immunology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Joyce A IbanaDepartment of Microbiology, Immunology and Parasitiology, Medical Education Building, Louisiana State University Health Sciences Center, 1901 Perdido St., New Orleans, LA 70112, USA.
Robert J Belland
Arnold H Zea
Danny J Schust
Takeshi Nagamatsu
Yasser M AbdelRahman
David J Tate
Wandy L Beatty
Ashok A Aiyar
Alison J Quayle
Louisiana State University Health Sciences Center New Orleans · USCairo University · EGUniversity of Missouri · USUniversity of Missouri Health System · USUniversity of Tennessee Health Science Center · USWashington University in St. Louis · US

Funding

T. vaginalis Recurrence Among HIV+ WomenU19AI061972 · NIAID · LSU HEALTH SCIENCES CENTER · PI MARTIN, DAVID H. · 2004 to 2009
$12.0M
Functions of EBNA1 in replication &partitioning of EBVR01CA112564 · NCI · NORTHWESTERN UNIVERSITY · PI AIYAR, ASHOK A · 2004 to 2009
$1.2M
NOVEL CELLULAR & GENETIC ANALYSES USING A NEW CHLAMYDIA PENETRANT PEPTIDER21AI095859 · NIAID · LSU HEALTH SCIENCES CENTER · PI AIYAR, ASHOK A, QUAYLE, ALISON J. · 2011 to 2012
$391k
Genetic Arrays for Antibiotic Target IdentificationR43AI055172 · NIAID · ELITRA PHARMACEUTICALS, INC. · PI YOUNGMAN, PHILIP J · 2003 to 2003
$109k
NCI NIH HHS CA 112564NCI NIH HHS R01 CA112564NIAID NIH HHS AI055172NIAID NIH HHS AI095859NIAID NIH HHS R21 AI095859NIAID NIH HHS U19 AI061972NIAID NIH HHS U19AI061972
6 · The paper itself

Abstract

Gamma interferon (IFN-γ) induces expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO1) in human epithelial cells, the permissive cells for the obligate intracellular bacterium Chlamydia trachomatis. IDO1 depletes tryptophan by catabolizing it to kynurenine with consequences for C. trachomatis, which is a tryptophan auxotroph. In vitro studies reveal that tryptophan depletion can result in the formation of persistent (viable but noncultivable) chlamydial forms. Here, we tested the effects of the IDO1 inhibitor, levo-1-methyl-tryptophan (L-1MT), on IFN-γ-induced C. trachomatis persistence. We found that addition of 0.2 mM L-1MT to IFN-γ-exposed infected HeLa cell cultures restricted IDO1 activity at the mid-stage (20 h postinfection [hpi]) of the chlamydial developmental cycle. This delayed tryptophan depletion until the late stage (38 hpi) of the cycle. Parallel morphological and gene expression studies indicated a consequence of the delay was a block in the induction of C. trachomatis persistence by IFN-γ. Furthermore, L-1MT addition allowed C. trachomatis to undergo secondary differentiation, albeit with limited productive multiplication of the bacterium. IFN-γ-induced persistent infections in epithelial cells have been previously reported to be more resistant to doxycycline than normal productive infections in vitro. Pertinent to this observation, we found that L-1MT significantly improved the efficacy of doxycycline in clearing persistent C. trachomatis forms. It has been postulated that persistent forms of C. trachomatis may contribute to chronic chlamydial disease. Our findings suggest that IDO1 inhibitors such as L-1MT might provide a novel means to investigate, and potentially target, persistent chlamydial forms, particularly in conjunction with conventional therapeutics.

Indexed as

Anti-Bacterial AgentsChlamydia trachomatisDose-Response Relationship, DrugDoxycyclineEpithelial CellsHeLa CellsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaKynurenineTime FactorsTryptophanAnti-Bacterial AgentsDoxycyclineIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaKynurenineTryptophantryptophan methyl ester

Identifiers

PMID21911470
PMCPMC3257928
OpenAlexW2133714264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.